Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Colorimetric Test Devised for Tuberculosis in Developing Areas

By LabMedica International staff writers
Posted on 28 Dec 2015
A rapid, sensitive and low-cost method has been devised for detecting tuberculosis (TB), a highly infectious disease and a major global health problem, especially in countries with developing health care systems. More...


The typical way that physicians screen for TB, which is caused by the bacterium Mycobacterium tuberculosis (Mtb), is with a tuberculin skin test or an examination of a patient's sputum under a microscope. To weed out false positives, a more reliable test that involves growing Mtb cultures can be performed, but that requires weeks to complete.

Scientists at the Australian Institute for Bioengineering and Nanotechnology (St Lucia, QLD, Australia) and their colleagues began with a newly created nucleic acid amplification test that does not require expensive laboratory equipment to detect Mtb, but this modified test typically uses costly fluorescence technology to read the results. The team substituted the fluorescence detector with a colorimetric assay that changes to a blue hue if the infection is present, allowing health care workers to identify positive test results right away with the naked eye.

The team employed a modified Solid Phase Reversible Immobilization (SPRI) protocol) with Guanidium-HCl lysis buffer to sample for genomic DNA (gDNA) from Mtb cells. Nucleic acid amplification was performed with the TwistAmp Basic RPA Kit (TwistDx Limited; Cambridge, UK). They devised a simple colorimetric assay that utilizes the chemical oxidation of 3,3′,5,5′-tetramethylbenzidine (TMB) by isothermally functionalized DNA targets as a sensitive and specific biosensor for the detection of tuberculosis. Absorbance was determined with the ND-1000spectrophotometer (NanoDrop; Wilmington, DE, USA). Ampometry responses were measured on a workstation potentiostat (CH Instruments; Austin, TX, USA).

The team demonstrated how the modified diagnostic could be put on cheap, disposable electrochemical sensors for increased sensitivity, even in the field. Because the assay is inexpensive, quick and highly specific for the Mtb bacterium, the scientists say it could have a big impact in low-resource communities. The assays are inexpensive at USD 3.00, takes only 75 minutes, sensitive as approaching a single cell, and highly specific to M. tuberculosis. The study was published on November 30, 2015, in the journal ACS Sensors.

Related Links:

Australian Institute for Bioengineering and Nanotechnology 
TwistDx Limited 
NanoDrop



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Silver Member
Rapid Test Reader
DIA5000
New
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.